A Phase 4 interventional study of Metoprolol (MET) and Sufentanil in General Anesthesia; Tracheal Intubation, sponsored by Fujian Provincial Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-20.
Sponsored by Fujian Provincial Hospital · Phase 4, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This randomized, double-blind, controlled clinical study will evaluate the effects of different dose combinations of intravenous metoprolol and sufentanil on cardiovascular responses during oral endotracheal intubation under general anesthesia.
Endotracheal intubation may cause transient increases in heart rate and blood pressure due to sympathetic stimulation. This study aims to determine whether metoprolol, in combination with different doses of sufentanil, can improve hemodynamic stability during and after intubation.
A total of 900 adult patients aged 18 to 65 years with American Society of Anesthesiologists physical status I or II who are scheduled for elective non-cardiac surgery under general anesthesia with endotracheal intubation will be enrolled. Participants will be randomly assigned to one of 30 groups according to the combination of metoprolol dose and sufentanil dose. Metoprolol doses include 0, 0.1, 0.2, 0.3, 0.4, and 0.5 mg/kg, and sufentanil doses include 0.1, 0.2, 0.3, 0.4, and 0.5 mcg/kg.
All participants will receive standardized anesthetic induction and maintenance. Hemodynamic changes will be observed for 10 minutes after intubation. The main outcome is the success rate of hemodynamic stability within 0 to 10 minutes after intubation. Secondary outcomes include the incidence of hypotension, hypertension, bradycardia, and tachycardia.
Fujian Provincial Hospital is the lead sponsor of 41 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Sufentanil · Drug: Normal Saline (0.9% NaCl)
Drug: Sufentanil · Drug: Normal Saline (0.9% NaCl)
Drug: Sufentanil · Drug: Normal Saline (0.9% NaCl)
Drug: Sufentanil · Drug: Normal Saline (0.9% NaCl)
Drug: Sufentanil · Drug: Normal Saline (0.9% NaCl)
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Drug: Metoprolol (MET) · Drug: Sufentanil
Metoprolol will be administered intravenously before anesthetic induction at the assigned dose of 0, 0.1, 0.2, 0.3, 0.4, or 0.5 mg/kg. The study drug will be given through a dedicated intravenous catheter, and each participant will receive the dose according to the randomized treatment arm.
Sufentanil will be administered intravenously during anesthetic induction at the assigned dose of 0.1, 0.2, 0.3, 0.4, or 0.5 mcg/kg. Each participant will receive sufentanil in combination with the assigned metoprolol dose according to the randomized treatment arm.
Normal saline (0.9% NaCl) will be administered intravenously before anesthetic induction as placebo in a volume matched to the metoprolol intervention. The study drug will be delivered through a dedicated intravenous catheter, and participants assigned to the placebo arm will receive a volume corresponding to the randomized dosing schedule used in the metoprolol groups.
Percentage of participants achieving hemodynamic stability after tracheal intubation
Time frame: within 0-10 min after intubation
incidence of bradycardia
Time frame: within 0-10 min after intubation
incidence of tachycardia
Time frame: within 0-10 min after intubation
incidence of hypotension
Time frame: within 0-10 min after intubation
incidence of hypertension
Time frame: within 0-10 min after intubation
adverse event
Time frame: up to 24 hours postoperatively
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jun 2026; primary completion for May 2027, 11 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Metoprolol · Sufentanil
Fujian Provincial Hospital